Sign in

You're signed outSign in or to get full access.

Dr. Bob Froehlich

About Dr. Bob Froehlich

Independent Trustee of Highland Opportunities and Income Fund (HFRO) since August 2017; born April 28, 1953. He is designated as one of the Trustees elected solely by holders of the Fund’s Preferred Shares, serves as Chairperson of the Governance and Compliance Committee, and is a member of both the Audit and Qualified Legal Compliance Committee and the Administration and Operations Committee. The Board met eight times in 2024 and each Trustee met at least the 75% attendance threshold; Froehlich is classified as independent under the 1940 Act and NYSE Rule 303A.02. The proxy highlights his significant financial industry experience, managerial/executive background, and prior audit committee service as core credentials .

Past Roles

OrganizationRoleTenureCommittees/Impact
KC Concessions, Inc.DirectorJan 2013 – Mar 2025Director role concluded March 2025
Kane County Cougars Baseball ClubChairman & OwnerJan 2013 – Mar 2025Club ownership/oversight; concluded March 2025
Midwest League of Professional Baseball Clubs, Inc.DirectorJan 2013 – Dec 2021Board service in professional baseball league
Kane County Cougars Foundation, Inc.Director; Executive DirectorDirector: Jan 2013 – Mar 2025; Executive Director: Jul 2023 – Mar 2025 (remains Director thereafter)Community/non-profit governance and operations leadership
Galen Robotics, Inc.DirectorAug 2016 – Sep 2023Private medical robotics board experience

External Roles

OrganizationRoleTenureNotes
American Sports Enterprise, Inc.DirectorSince Jan 2013Ongoing board role
Vault Data, LLCDirector & Special AdvisorSince Feb 2018Data/technology advisory and governance
American Association of Professional Baseball, Inc.DirectorSince Feb 2021Independent league governance
National Amateur Fall Baseball FederationDirectorSince Dec 2023Amateur baseball governance

Board Governance

  • Board composition: five Trustees (four independent; one interested). Chairman: Ethan Powell (Independent). Independent Trustees meet as needed with independent counsel without management present .
  • Preferred Share representation: Froehlich is designated as one of the Trustees elected solely by Preferred Shareholders; his Class II seat is up for re-election at the 2026 annual meeting by Preferred holders only .
  • Attendance and engagement: Board convened 8 times in 2024; each Trustee attended at least 75% of Board and Committee meetings served .
  • Risk and valuation oversight: The Audit Committee oversees financial reporting and audits and also oversees valuations under Rule 2a-5, with the Adviser designated as valuation designee; Audit met 5 times in 2024 .
  • Committee structure and 2024 activity (Froehlich’s roles in bold):
    CommitteeRole2024 Meetings
    Audit & Qualified Legal ComplianceMember5
    Governance & ComplianceChairperson5
    Administration & OperationsMember5

Fixed Compensation

  • Structure (2024): Annual Trustee retainer $150,000; no meeting fees; Chairperson of each Committee receives additional $10,000; Chairman of the Board receives $20,000; no pension/retirement plan .
  • Structure (2023 comparator): Annual retainer $150,000; additional $10,000 for Chairman of the Board and $10,000 for Audit Committee Chair; no pension/retirement plan .
YearComponentAmountNotes
2024Annual Trustee Retainer$150,000Paid across Fund Complex; allocated by net assets
2024Committee Chair Fee$10,000Per committee chair; Froehlich as Governance & Compliance Chair
2024Chairman of the Board Fee$20,000Applies to Board Chair (not Froehlich)
2023Annual Trustee Retainer$150,000Paid across Fund Complex
2023Chairman of the Board Fee$10,000Not applicable to Froehlich (not Chair)
2023Audit Chair Fee$10,000For Audit Chair (not Froehlich)
Dr. Bob Froehlich – Reported Compensation20232024
Aggregate Compensation From the Fund$52,269 $68,289
Aggregate Compensation From the Fund Complex$150,000 $160,000
Pension/Retirement Benefits$0 $0

Performance Compensation

Plan/MetricDisclosure
Stock awards (RSUs/PSUs)None disclosed in the proxy; Trustee pay described as cash retainers and chair fees; no equity plan referenced .
Option awardsNone disclosed .
Bonus/Performance metrics (TSR, EBITDA, ESG)None disclosed for Trustees .
Clawbacks/COC/SeveranceNot applicable to independent Trustees; not disclosed .

Other Directorships & Interlocks

  • No current public company directorships are disclosed for Froehlich; disclosed roles are private company, league, or non-profit boards (see External Roles) .
  • No beneficial ownership by Independent Trustees or their immediate family of securities issued by the Adviser, principal underwriter, or related parties, reducing interlock/conflict risk .

Expertise & Qualifications

  • Significant experience in the financial industry; substantial managerial and executive experience; extensive board service, including audit committees—cited as key attributes supporting his Board role .

Equity Ownership

As of DateHolderHFRO Share OwnershipAggregate Ownership Across Fund ComplexNotes
Feb 28, 2025Dr. Bob Froehlich$10,001–$50,000 (dollar range) Over $100,000 Ranges reported; no share count disclosed
Feb 28, 2025All Trustees & Officers (group)<0.01% of outstanding shares Indicates modest alignment at group level
Feb 28, 2025Independent Trustees/adjoining familyNone owned securities of Adviser/underwriter/affiliates

Governance Assessment

  • Strengths:

    • Independence and structure: Froehlich is independent under the 1940 Act and NYSE rules; Audit and Governance & Compliance Committees are chaired by Independent Trustees; Independent Trustees meet with independent counsel without management present .
    • Engagement: Board (8 meetings) and committees (5 each) indicate regular cadence; all Trustees met at least 75% attendance .
    • Conflict oversight: As Governance & Compliance Chair, Froehlich leads board oversight of legal/regulatory compliance and potential conflicts between the Fund and NexPoint related to securities/litigation—central to investor protection .
    • Valuation oversight: Audit Committee oversight of valuations under Rule 2a‑5 provides a defined control framework around fair value determinations .
  • Alignment and Risks:

    • Low direct ownership: Froehlich’s reported HFRO ownership is $10k–$50k, and Trustees/officers as a group own <0.01% of shares—alignment exists but is modest (common in registered fund complexes) .
    • Cash-only director pay: Compensation is retainer-based cash with chair adders; no equity/long-term performance components disclosed—limited direct pay-for-performance linkage for directors .
    • Capital structure nuance: Froehlich’s seat is elected solely by Preferred Shareholders (Class II), which can create a different constituency focus versus common shareholders; this is permitted by HFRO’s governing documents .
  • Compensation governance evolution:

    • Chair fees changed YoY: 2023 structure paid $10k to Board Chair and Audit Chair; 2024 provides $20k to Board Chair and $10k to each Committee Chair—clarifies committee leadership compensation while holding base retainer flat .
  • Disclosures:

    • No related-party holdings by Independent Trustees or immediate family in the Adviser/underwriter entities were disclosed, mitigating direct financial interlock concerns .
    • Section 16 compliance noted (prior year proxy), with no delinquencies indicated for officers/Trustees; no Form 4 trading detail provided in the HFRO proxy .

RED FLAGS to monitor: very low group ownership (<0.01%); absence of equity-based director compensation; and the preferred-shareholder election mechanism for Froehlich’s seat, which may be perceived as a structural alignment nuance relative to common shareholders .